The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

SOME PROGNOSTIC CRITERIA FOR THE RESPONSE OF SCHIZOPHRENIC PATIENTS TO INSULIN TREATMENT

Published Online:https://doi.org/10.1176/ajp.97.6.1397

A study was made of 37 schizophrenic patients in an attempt to discover factors related to their response to insulin shock treatment. Of good prognostic significance were found to be:

1. The presence of atypical schizophrenia.

2. The presence of considerable emotional reaction.

3. A history of some attempt at sexual adaptation.

4. Manifestation of sexual interest in the psychotic state.

The patients who reacted poorly to the treatment

1. Very frequently came from a poorly integrated family with little solidarity among its members.

2. In many instances as children they were considered in some respect different from the other siblings.

3. They adapted to school in a somewhat worse than average fashion and showed a lack of ambition.

4. They showed very little sexual interest prior to the psychosis and there were no overt sexual manifestations other than autoeroticism during the psychosis.

5. Almost all of the patients who exhibited autistic behavior (mannerisms, grimacing, posturing, etc.) failed to respond.

6. They showed a picture of typical schizophrenia without extraneous admixtures.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.